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ABSTRACT
Objective: Largely, watchful waiting is the initial
policy for patients with small-sized or medium-sized
vestibular schwannoma, because of slow growth and
relatively minor complaints, that do not improve by an
intervention. If intervention (microsurgery, radiosurgery
or fractionated radiotherapy) becomes necessary, the
choice of intervention appears to be driven by the
patient’s or clinician’s preference rather than by
evidence based. This study addresses the existing
evidence based on controlled studies of these
interventions.
Design: A systematic Boolean search was performed
focused on controlled intervention studies. The quality
of the retrieved studies was assessed based on the
Sign-50 criteria on cohort studies.
Data sources: Pubmed/Medline, Embase, Cochrane
Central Register of Controlled Trials and reference lists.
Study selection: Six eligibility criteria included a
controlled intervention study on a newly diagnosed
solitary, vestibular schwannoma reporting on clinical
outcomes. Two prospective and four retrospective
observational, controlled studies published before
November 2011 were selected.
Data analysis: Two reviewers independently
assessed the methodological quality of the studies and
extracted the outcome data using predefined formats.
Results: Neither randomised studies, nor controlled
studies on fractionated radiotherapy were retrieved. Six
studies compared radiosurgery and microsurgery in a
controlled way. All but one were confined to solitary
tumours less than 30 mm in diameter and had no
earlier interventions. Four studies qualified for
trustworthy conclusions. Among all four, radiosurgery
showed the best outcomes: there were no direct
mortality, no surgical or anaesthesiological
complications, but better facial nerve outcome, better
preservation of useful hearing and better quality of life.
Conclusions: The available evidence indicates
radiosurgery to be the best practice for solitary
vestibular schwannomas up to 30 mm in cisternal
diameter.
INTRODUCTION
Vestibular schwannoma, also called acoustic
neuroma, is not an uncommon benign brain
tumour. It accounts for about 6% of all intra-
cranial tumours.1 A reliable register is available
in Denmark, since almost all patients with a
vestibular schwannoma are referred to one
specialist clinic. The incidence approaches 20
per million per year.2 Owing to its benign
nature the prevalence accumulates to 200
per million.3 The tumour originates from
the Schwann cells of the vestibular section of
the vestibulocochlear nerve at the borders
of the central and peripheral myelin, usually
slightly lateral to the rim of the internal
auditory meatus. A vestibular schwannoma
visualises characteristically at MRI (ﬁgure 1).
In combination with symptoms like asymmet-
ric hearing loss, tinnitus, vertigo or imbalance,
the diagnosis is accepted without histological
ARTICLE SUMMARY
Article focus
▪ Search for the best practice if an intervention for
solitary vestibular schwannoma is considered
necessary.
▪ Systematic review of evidence from controlled
intervention studies on the effectiveness of inter-
ventions for solitary vestibular schwannomas.
Key messages
▪ The literature search yielded cohort studies com-
paring microsurgery and radiosurgery.
▪ Quality assessment showed four studies likely to
give unbiased results.
▪ Radiosurgery consistently emerges as the best
practice for tumours smaller than 30 mm in cis-
ternal diameter.
Strengths and limitations of this study
▪ All eligible studies compared the same interven-
tions: microsurgical excision and radiosurgery.
▪ All four trustworthy controlled studies pointed to
the same intervention as the best practice.
▪ Patients’ outcomes in the assessed comparative
studies are in accordance with long-term out-
comes in sizeable contemporary case-series.
▪ The conclusion is limited to solitary vestibular
schwannomas smaller than 30 mm.
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veriﬁcation. The majority grows slowly or not at all; the
average growth is 1–2 mm/year.4 5 However, if the tumour
grows, the rate in the ﬁrst year is on an average 5–10 mm.6
There are no parameters known that predict which
tumour will grow and to what extent.7 8
The mild natural course and relatively minor symp-
toms—that do not improve by any intervention—justiﬁes
for small-sized and medium-sized tumours an initial
policy of watchful waiting by sequential MRI follow-up.
However, if the tumour is sizeable and obliterates the
cistern of the cerebellopontine angle (CPA) or grows
substantially during the follow-up, in principal, an inter-
vention is indicated. In most centres, the choice is
between microsurgical resection for any tumour size and
radiosurgery for small-sized and medium-sized tumours
or stereotactic radiotherapy for tumours over 25–30 mm
diameter. Numerous case series and non-systematic
reviews have been summarised recently by Arthurs et al.4
Understandably, owing to inherent limitations of case
series, these reviewers did not arrive at ﬁrm conclusions.
In this study, we limit our search for the best practice to
comparative, controlled trials on interventions for ves-
tibular schwannoma in a systematic and qualitative way.
METHODS
PubMed and Embase were searched in November 2011
for controlled intervention studies on vestibular schwanno-
mas. We imposed no restrictions on the kind of interven-
tion or patient characteristics. We performed Boolean
searches using the following keywords (‘vestibular schwan-
noma’ OR ‘acoustic neuroma’ NOT neuroﬁbromatoses)
and (management OR therapy OR treatment OR inter-
vention) and (‘controlled trial’ OR ‘controlled study’ OR
‘clinical trial’) or (comparative OR comparison OR com-
pared) (see online supplementary appendix 1). No lan-
guage, publication status or other search restriction was
imposed. The retrieved articles were screened by title and
if necessary by abstract. Eventually 13 full text articles were
examined. The reference lists of studies meeting the eligi-
bility criteria were checked. We also searched the
Cochrane Central Register of Controlled Trials without
ﬁnding further studies. The six eligibility criteria included
controlled, intervention study on a newly diagnosed, soli-
tary vestibular schwannoma reporting on clinical outcome.
The two neurosurgeons of our team appraised the arti-
cles for inclusion and assessed the risk of bias in the indi-
vidual studies. The quality was assessed by judging criteria
that were considered relevant by the team. The assessment
is based on the Sign-50 quality criteria for cohort studies.
(Our criteria are enlisted in table 1) (http://www.ahrq.
gov/clinic/epcix.htm: AHRQ Publication No. 02-E016,
April 2002, http://www.sign.ac.uk/guidelines/fulltext/
50/annexc.html: checklist and notes on cohort studies,
annexe C).9 We abstracted the primary clinical outcome
data: mortality, treatment failure (that is second interven-
tion necessary), function of cranial nerves 7 and 8, other
intervention-associated complications and the data on
quality of life. These outcome measures are the most
important to the patient. Secondary outcome measures,
being duration of hospital stay and time off work were also
addressed. Table 1 on risk of bias and table 3 on outcome
measures served as a predeﬁned format for data extrac-
tion. Disagreements between the two reviewers were
resolved by consensus.
RESULTS
No randomised clinical trials on solitary vestibular
schwannoma were found. Only two studies—both
comparing microsurgical excision with radiosurgery—
showed up that had a controlled, prospective design
with predeﬁned inclusion criteria.10 11 The search
retrieved another four retrospective cohort studies with
a matched control group, all comparing again microsur-
gery and radiosurgery.12–15 We identiﬁed no controlled
studies involving fractionated stereotactic radiotherapy
(ﬁgure 2).
Figure 1 Axial T2-weighted MRI with a still visible
CSF-interface between tumour and brain. The largest
diameter of the tumour in the CPA cistem is 14 mm. Yellow:
vestibular schwannoma; green: labyrinth; red: ipsilateral and
contralateral facial nerve; blue: ipsilateral and contralateral
vestibulocochlear nerve; white: brainstem and cerebellar
peduncle; purple: caudal temporal lobe; pink: basilar artery.
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Table 1 Checklist on cohort studies based on SIGN 50 comparing microsurgery (MS) and radiosurgery (RS) for solitary vestibular schwannoma
Authors and publication year Pollock 200610 Myrseth 200911 Pollock 199512 Myrseth 200515 Regis 200214 Karpinos 200213
Design Prospective
consecutive
predefined inclusion
criteria
Prospective
consecutive
predefined inclusion
criteria
Retrospective
consecutive
matched controls
Retrospective
consecutive
matched controls
Retrospective non-
consecutive matched
controls
Retrospective
consecutive matched
controls
Allocation to treat arm Preference patient Preference patient Preference patient
and surgeon
Preference patient 2 hospitals,
preference by
surgeon/patient
Miscellaneous
criteria by surgeon
Same primary endpoint:
intervention-associated morbidity
Yes Yes Yes Yes Yes Yes
Selection of subjects
Source population: adult, solitary
VS<30 mm, no previous
intervention
Yes Yes Yes Yes Yes No
Eligibility criteria: proven growth
or predefined cisternal size
No Yes No No No No
Exclusion criteria NOT more
strict for MS because of age and
comorbidity
Yes No No No No No
Participation rate NOT lower for
MS because of specific RS
referral
Yes No No No No No
Same baseline cranial nerve
deficits
Yes Yes Yes Yes No Yes
Consecutive series and loss to
follow-up <10%
Yes Yes Yes Yes No No
Adequate analysis drop outs Yes Yes No Yes No No
Outcome assessment
Prespecified endpoint Yes Yes Yes Yes Yes Yes
Mortality addressed Yes Yes No Yes Yes Yes
Blinded outcome measurement Yes No No No No No
Same measure new cranial
nerve deficit
Yes Yes Yes Yes Yes Yes
Same measure quality-of-life
scores
Yes Yes Yes Yes Yes No
Repeated outcome
measurement
Yes Yes Yes Yes Yes No
Confounding variables
NOT substantial larger tumour
size in MS arm
Yes Yes Yes Yes Yes No
NOT substantial higher age in
RS arm
No Yes No No No No
NOT less fit patients in RS arm Yes No No No No No
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Four main quality items were assessed: selection of sub-
jects, outcome measure, known confounders and statistical
analysis (table 1). At the inception, in ﬁve out of six
studies all patients were at the same stage of the disease
having minor symptoms, tumour size limited to 30 mm
extension into the CPA and no earlier intervention. ne
exception is the study of Karpinos et al,13 which included
recurrent tumours. The indication for an intervention was
clearly deﬁned in only one study.11 In the other studies,
just having a vestibular schwannoma seemed sufﬁcient to
initiate an intervention, be it excision or radiosurgery.
Baseline patient characteristics were quite similar in the
treatment arms within the studies (table 2). Only the
average age was higher in all radiosurgery arms. Speciﬁc
allocation to the radiosurgery arm because of comorbidity
or high age was permitted in all but the study of Pollock
et al.10 These are known hazards for a favourable outcome.
If imbalance was present, the higher risk patients were in
the radiosurgery arms. There was minimal or no loss to
follow-up in all but one study.13 After summation of the
number of items that downgrade the conﬁdence in
outcome (bold No in table 1), four studies remained that
showed trustworthy association between interventions and
outcomes. 10–12 15 The outcomes are speciﬁed in table 3.
There was 1% mortality in two microsurgery arms.14 15
After radiosurgery, there was no mortality and no surgical
or anaesthetic complications, but better facial function,
better hearing preservation and better quality of life.
DISCUSSION
Microsurgery and radiosurgery are equally effective
interventions for vestibular schwannomas as demon-
strated by numerous case series that were recently
reviewed.4 While taking into account patients’ individual
preferences, ideally the choice of treatment should be
based on high-quality evidence from well-conducted clin-
ical trials. We found evidence of greater clinical effective-
ness of radiosurgery compared with that of microsurgery
in medium-sized tumours.
Systematic reviews of randomised clinical trials—pref-
erably double-blinded—are considered the gold stand-
ard of evidence-based practice. Regarding vestibular
schwannomas, however, we most probably will have to do
without randomised studies. Indeed, Myrseth et al11
failed to go on with their randomised trials, because
patients were reluctant to accept chance to decide
whether they would undergo surgery or radiosurgery.11
Next best evidence is obtained from well-designed non-
randomised controlled trials.16 17 Next to the value of
well-conducted randomised trials, the value of high-
quality observational studies is validated by the remark-
able similar results, which were observed when compar-
ing speciﬁc treatments through both randomised and
observational trials.18–20 Such observational studies may
provide trustworthy information on the risks of the inter-
vention, on adverse events and ultimately on the quality
of life of patients. Overall, these patients are more
Ta
b
le
1
Co
nt
in
ue
d
A
u
th
o
rs
an
d
p
u
b
lic
at
io
n
ye
ar
P
o
llo
ck
20
06
1
0
M
yr
se
th
20
09
1
1
P
o
llo
ck
19
95
1
2
M
yr
se
th
20
05
1
5
R
eg
is
20
02
1
4
K
ar
p
in
o
s
20
02
1
3
O
ne
si
ng
le
in
te
rv
en
tio
n
in
ea
ch
ar
m
Y
es
Y
es
Y
es
Y
es
Y
es
N
o
S
ta
tis
tic
al
an
al
ys
is
S
ta
tis
tic
al
m
ea
su
re
of
pr
ec
is
io
n
Y
es
Y
es
Y
es
Y
es
Y
es
Y
es
O
ve
ra
ll
as
se
ss
m
en
t
N
um
be
r
of
re
le
va
nt
‘n
o’
0
0
0
0
3
6
O
ve
ra
ll
ju
dg
em
en
t
+
+
+
+
+
+
−
−
N
o
co
m
m
er
ci
al
fu
nd
in
g
Y
es
Y
es
Y
es
Y
es
Y
es
Y
es
N
o
re
le
va
nt
bi
as
,
ou
tc
om
e
ow
in
g
to
in
te
rv
en
tio
n
Y
es
Y
es
Y
es
Y
es
N
o
N
o
O
ut
co
m
e
ap
pl
ic
ab
le
to
so
ur
ce
po
pu
la
tio
n
Y
es
Y
es
Y
es
Y
es
N
o
N
o
Y
es
:
w
el
lc
ov
er
ed
or
ad
eq
ua
te
ly
ad
dr
es
se
d,
in
cr
ea
si
ng
co
nf
id
en
ce
th
at
ou
tc
om
e
is
ca
us
ed
by
th
e
in
te
rv
en
tio
ns
.
N
o:
po
or
ly
or
no
t
ad
dr
es
se
d
or
no
tr
ep
or
te
d;
ca
us
e
fo
r
bi
as
.
B
ol
d:
po
ss
ib
le
re
le
va
nt
bi
as
,
de
cr
ea
si
ng
co
nf
id
en
ce
.
+
+
,A
ll
or
m
os
to
f
th
e
cr
ite
ria
ha
ve
be
en
fu
lfi
lle
d.
W
he
re
th
ey
ha
ve
no
t
be
en
fu
lfi
lle
d
th
e
co
nc
lu
si
on
s
of
th
e
st
ud
y
or
re
vi
ew
s
ar
e
th
ou
gh
t
to
be
ve
ry
un
lik
el
y
to
al
te
r.
+
,S
om
e
of
th
e
cr
ite
ria
ha
ve
be
en
fu
lfi
lle
d.
T
ho
se
cr
ite
ria
th
at
ha
ve
no
t
be
en
fu
lfi
lle
d
or
no
ta
de
qu
at
el
y
de
sc
rib
ed
ar
e
th
ou
gh
tu
nl
ik
el
y
to
al
te
r
th
e
co
nc
lu
si
on
s.
−
,F
ew
or
no
cr
ite
ria
fu
lfi
lle
d.
T
he
co
nc
lu
si
on
s
of
th
e
st
ud
y
ar
e
th
ou
gh
tl
ik
el
y
or
ve
ry
lik
el
y
to
al
te
r.
4 Wolbers JG, Dallenga AHG, Mendez Romero A, et al. BMJ Open 2013;3:e001345. doi:10.1136/bmjopen-2012-001345
Systematic review of controlled intervention studies for vestibular schwannoma
 group.bmj.com on April 4, 2013 - Published by bmjopen.bmj.comDownloaded from 
similar to the general disease population than those
complying with the strict inclusion and exclusion criteria
of a randomised clinical trial. Such high quality of obser-
vational studies is achieved by studying the same inter-
vention by the same outcome measures in well-matched
patient population without dropouts. Based on Sign-50,
this is the basic thought behind the assessment of
quality of individual studies in table 1.
Selection of subjects
All retrieved controlled studies compared the same two
interventions and consistently pointed to radiosurgery as
being the best intervention for their research question.
Some studies, however, provide more conﬁdence to have
unbiased results, as elucidated in table 1. A major risk of
bias of all observational studies is that the compared
groups are substantially unequal in their initial suscepti-
bility to the outcome. In ﬁve studies the selection bias is
reasonably controlled, since the compared groups are
very similar except for the interventions under study.
Only in the study by Karpinos et al13 the source popula-
tion differed due to inclusion of patients having had
earlier surgery for the same disease. In addition, this
study had an unacceptably high loss to follow-up of over
20%. These two serious sources of bias prevented a
favourable overall good quality judgement. In one study
pertinent bias arose, because of non-consecutive inclu-
sion in the microsurgery arm.14
Only Myrseth et al11 clearly deﬁned the starting point
of an intervention. Nevertheless, confounding by indica-
tion between the various studies appears unlikely, since
major adverse events, like disabling neurological deﬁcits,
do not occur in the natural history of vestibular schwan-
nomas smaller than 30 mm. It is very implausible that
any of the major adverse events occur in the absence of
an intervention. Therefore, the risk that an adverse
outcome occurs by chance instead of being related to
the intervention is not realistic and we assigned no rele-
vance to the potential confounder of being at various
points in the disease progression (non-bold No, table 1).
Outcome assessment
All but one study reported on the same clinical outcome
measures, which are: failure because a second interven-
tion was needed, function preservation of the involved
cranial nerves, more general complications and quality
of life. The exception is the study by Karpinos et al, who
did not report on quality of life. All used established
classiﬁcations of facial motor function and useful
hearing.
Only one group managed a blinded outcome measure-
ment.10 Taking into account that a troublesome
outcome—when occurring—is quite clear-cut in this
disease, non-blinded outcome measurement did not
depreciate our trust that the reported outcome is true and
caused by the speciﬁc intervention. Typically, repeated
measurements increase this trust further.
Confounding variables
A previous treatment for the same disease induces relevant
bias, because of different baseline characteristics and an
inherent higher risk for adverse events. As mentioned
already, this applied to the study of Karpinos et al,13
because the results from ﬁrst and second interventions
were not separated in their report. Frail patients were in all
but the study of Pollock et al
10
inclined to end up in the
radiosurgery arm. In general higher age, comorbidity and
larger tumours are drawbacks for a good outcome. In
those studies showing signiﬁcant imbalance of these vari-
ables the potential disadvantage, however, was at the side
of radiosurgery, which nevertheless produced the best
outcome in all studies.12 13 15 As these imbalances work in
Table 2 Patients’ preintervention characteristics; only sporadic vestibular schwannomas
Author
publication
year
Intervention
included
(no.)
Male:
Female
Age
(years)
n.
trigeminal
deficit %
n. facial
deficit
(%)†
Useful
hearing
(%)‡
Tumour
size§
(mean mm)
Previous
treatment
(%)
Pollock 200610 MS: 36
RS: 46
19:17
27:19
48
54
0
0
0
0
61
65
14
12
No
No
Myrseth 200911 MS: 28
RS: 60
12:16
36:24*
53
58
?
?
0
0
44
42
18
16
No
No
Pollock 199512 MS: 40
RS: 47
18:22
23:24
51
62*
10
6
5
2
12
4
>20 mm: 18%
>20 mm: 29%
No
No
Myrseth 200515 MS: 86
RS: 103
?
?
50
60*
20
12
1
1
2
10
>20 mm: 32%
>20 mm: 17%
No
No
Regis 200214 MS: 110
RS: 100
M 35%
M 46%
52
61
55
20
?
2
?
49
KoosIII: 55%§
KoosIII: 34%
No
No
Karpinos 200213 MS: 23
RS: 73
6:17
23:50
45
62*
30
17
26
10
30
24
>40 mm: 17*
>40 mm: 3%
26
14
MS: microsurgery, RS: radiosurgery.
*Significant (p<0.05).
†Percentage preserved, House-Brackmann grade 1–2.
‡Useful hearing: AAO-HNS class A–B or Gardner–Robertson grade I–II.
§KoosIII: tumour occupying the cerebellopontine cistern without brainstem displacement.
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favour of microsurgery, we considered them not relevant
(non-bold Nos in table 1).
The overall assessment of study quality gave conﬁ-
dence in four studies, because no relevant biases were
identiﬁed. Quite importantly, all four consistently
showed a signiﬁcant advantage for radiosurgery over
microsurgical excision, when directly compared in a con-
trolled manner (table 2).
One might argue that a weakness of some of the four
trustworthy studies is the relative small numbers and short
follow-up. However, patients’ outcome in the assessed com-
parative studies is in accordance with the long-term
outcome in sizeable contemporary radiosurgery series as
summarised in online supplementary appendix 2.21–25
Radiosurgery for vestibular schwannoma is a day case with
2% (median) of patients requiring additional treatment;
less than 1% (median) experienced some facial neur-
opathy and trigeminal neuropathy occurred in 5%
(median). It has no direct mortality and the risk of incap-
acitating complications is negligible or non-existing. The
comprehensive review of Arthurs et al showed that after
microsurgery less than 2% of patients required additional
treatment. The rates of facial nerve palsy are as high as 10–
30%, varying with tumour size.4 These numbers are of the
same range in the comparative studies on tumours limited
to a size of 3 cm in table 2. Not mentioned in any detail by
Arthurs et al are other surgical morbidities, which are not
trivial at all, being between 14% and 47% in the compara-
tive studies. Major adverse events like mortality and dis-
charge to long-term care may occur after microsurgery in
about 0.5% and 1.2%, respectively.26
Not addressed in the comparative studies is the risk of
secondary cancer after radiation for a benign tumour
causing mortality. Indeed, radiation-associated tumours do
occur after sufﬁcient follow-up of 5–20 years. So far, 12
cases of radiosurgery-associated malignant tumours have
been reported worldwide.27 Based on model calculations
the probability of a malignant tumour after radiosurgery is
estimated at 1 per 1000.28 Distinctively, the hospital-based
study mentioned herein before depicted 2643 surgeries in
265 US hospitals for vestibular schwannoma and showed a
3-month mortality of 0.5%.26 If radiosurgery is not
employed too enthusiastically owing to its low threshold,
but on proper indication, the risk of death by a
radiation-induced tumour is not relevant in comparison to
the (few) possible direct disasters of microsurgery.
Undeniably, the mortality is much smaller and, if it occurs,
it may do so many years later in a patient’s life.
Looking for the best practice, one should realise indeed
that the results of various health-related quality-of-life
studies after surgery called for modesty. Deterioration of
the well-being of the patient proved difﬁcult to avoid, even
in elective surgery of relatively small tumours.29–31 In add-
ition, the comparative studies showed deterioration in the
quality of life as high as in 30–45% of patients operated on
(table 3). Once an intervention is considered necessary,
we conclude based on this systematic review of controlled
studies, that radiosurgery is the best practice for patients
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with solitary vestibular schwannoma up to 30 mm in cister-
nal extension.
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